BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 36104010)

  • 1. Evaluation of
    Wu Y; Wang Y; Yang Z; Teng C; Guo Z
    Thorac Cancer; 2022 Nov; 13(21):3025-3031. PubMed ID: 36104010
    [TBL] [Abstract][Full Text] [Related]  

  • 2.
    Xiao L; Yu S; Xu W; Sun Y; Xin J
    Korean J Radiol; 2023 Nov; 24(11):1142-1150. PubMed ID: 37899523
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [
    Zheng S; Chen Z; Huang C; Chen Y; Miao W
    Ann Nucl Med; 2019 Feb; 33(2):135-143. PubMed ID: 30392070
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of
    Zheng J; Miao W; Huang C; Lin H
    Ann Nucl Med; 2017 Jul; 31(6):486-494. PubMed ID: 28474165
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of [
    Chen Z; Fu F; Li F; Zhu Z; Yang Y; Chen X; Jia B; Zheng S; Huang C; Miao W
    Mol Imaging Biol; 2018 Oct; 20(5):846-856. PubMed ID: 29497956
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Integrin Imaging with
    Jin X; Liang N; Wang M; Meng Y; Jia B; Shi X; Li S; Luo J; Luo Y; Cui Q; Zheng K; Liu Z; Shi J; Li F; Wang F; Zhu Z
    Radiology; 2016 Dec; 281(3):958-966. PubMed ID: 27479638
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Advantages of
    Lv N; Gao S; Bai L; Ji B; Xue J; Ge X; Chen B
    Ann Nucl Med; 2019 Jan; 33(1):39-46. PubMed ID: 30218281
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Noninferiority of
    Dai D; Rollo FD; Bryant J; Kim EE
    Contrast Media Mol Imaging; 2018; 2018():8969714. PubMed ID: 29736155
    [No Abstract]   [Full Text] [Related]  

  • 9. ⁹⁹mTc-3PRGD₂ SPECT to monitor early response to neoadjuvant chemotherapy in stage II and III breast cancer.
    Ji B; Chen B; Wang T; Song Y; Chen M; Ji T; Wang X; Gao S; Ma Q
    Eur J Nucl Med Mol Imaging; 2015 Aug; 42(9):1362-70. PubMed ID: 25947573
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 99mTc-3PRGD2 for integrin receptor imaging of lung cancer: a multicenter study.
    Zhu Z; Miao W; Li Q; Dai H; Ma Q; Wang F; Yang A; Jia B; Jing X; Liu S; Shi J; Liu Z; Zhao Z; Wang F; Li F
    J Nucl Med; 2012 May; 53(5):716-22. PubMed ID: 22499615
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of the diagnostic and prognostic values of 99mTc-MDP-planar bone scintigraphy, 131I-SPECT/CT and 18F-FDG-PET/CT for the detection of bone metastases from differentiated thyroid cancer.
    Qiu ZL; Xue YL; Song HJ; Luo QY
    Nucl Med Commun; 2012 Dec; 33(12):1232-42. PubMed ID: 23111353
    [TBL] [Abstract][Full Text] [Related]  

  • 12. (99m)Tc-3PRGD2 SPECT/CT Imaging for Monitoring Early Response of EGFR-TKIs Therapy in Patients with Advanced-Stage Lung Adenocarcinoma.
    Zhang Z; Zhao X; Ding C; Wang J; Zhang J; Wang F
    Cancer Biother Radiopharm; 2016 Sep; 31(7):238-45. PubMed ID: 27563805
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Imaging of Integrin α
    Song YS; Park HS; Lee BC; Jung JH; Lee HY; Kim SE
    Cancer Biother Radiopharm; 2017 Oct; 32(8):288-296. PubMed ID: 29053416
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combined 18F-FDG PET/CT and 99mTc 3PRGD2 SPECT/CT imaging in a case of pituitary metastases.
    Hou Y; Zhu Z; Jin X; Wang R; Xing B
    Clin Nucl Med; 2013 Jul; 38(7):550-2. PubMed ID: 23657139
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical Value of
    Gao R; Zhang GJ; Wang YB; Liu Y; Wang F; Jia X; Liang YQ; Yang AM
    Sci Rep; 2018 Jan; 8(1):473. PubMed ID: 29323252
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular imaging of HER2 expression in breast cancer patients using a novel peptide-based tracer
    Shi J; Du S; Wang R; Gao H; Luo Q; Hou G; Zhou Y; Zhu Z; Wang F
    J Transl Med; 2023 Jan; 21(1):19. PubMed ID: 36631812
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A brief evaluation of tumor imaging in mice with 99mTc-glucarate including a comparison with 18F-FDG.
    Cheng D; Rusckowski M; Wang Y; Liu Y; Liu G; Liu X; Hnatowich D
    Curr Radiopharm; 2011 Jan; 4(1):5-9. PubMed ID: 22191610
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Noninvasive detection of human-induced pluripotent stem cell (hiPSC)-derived teratoma with an integrin-targeting agent (99m)Tc-3PRGD2.
    Li Y; Liu Z; Dong C; He P; Liu X; Zhu Z; Jia B; Li F; Wang F
    Mol Imaging Biol; 2013 Feb; 15(1):58-67. PubMed ID: 22707047
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of Tc-99m-3PRGD2 Integrin Receptor Imaging in the Differential Diagnosis of Breast Lesions and Comparison With Mammography.
    Chen G; Ouyang Z; Wang F; Wu H; Jia B; Chordia MD
    Cancer Invest; 2017 Feb; 35(2):108-115. PubMed ID: 28135863
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 99mTc-3PRGD2 single-photon emission computed tomography/computed tomography for the diagnosis of choroidal melanoma: A preliminary STROBE-compliant observational study.
    Yan B; Fu T; Liu Y; Wei W; Dai H; Fang W; Wang F
    Medicine (Baltimore); 2018 Oct; 97(40):e12441. PubMed ID: 30290601
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.